AKT1 and fatty liver disease: Similarly, the main active ingredient in PSO, ALA, has been shown to attenuate hepatic steatosis in the HFD-induced rats via endoplasmic reticulum stress-mediated autophagy and the PI3K/Akt pathway [59].